Skip To Main Content
Arnon P Kater on Muck Rack

Arnon P Kater

As seen in: Nature, Wiley Online Library, ScienceDirect, MDPI, The New England Journal of Medicine, The Lancet, OncLive
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Arnon P

Contact Arnon P, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Necroptotic cell death and immunomodulator release induced by T-cell engaging anti-lymphoma therapies

|
By José Saura-Esteller, Anne Martens, Jan Willem Duitman, Nicole N. van der Wel, Arnon P Kater, Marco Haselager, Eric Eldering, Joanne Rietveld, Ingrid Derks, Morris Mes, Anita Grootemaat
| Nature Verified
Abstract Autologous cellular immunotherapies, which rely on cytotoxic T lymphocytes (CTLs), are increasingly applied in different B-cell malignancies. The general assumption is that CTLs exert their cytolytic function through granzymes that induce apoptosis in the target cell. However, the killing mechanism of immunotherapeutic CTLs is not clearly elucidated.
Open in Who Shared Issue with article?

Epcoritamab monotherapy for Richter transformation (EPCORE CLL-1): findings from a single-arm, multicentre, open-label, phase 1b/2 trial

|
By Arnon P Kater, Ann Janssens, Hospitals Gasthuisberg Leuven, Herbert A Eradat
| The Lancet Verified
Get full text access Log in, subscribe or purchase for full access. References 1. Hess, B ∙ Kalmuk, J ∙ Znoyko, I ∙ et al. Clinical utility of chromosomal microarray in establishing clonality and high risk features in patients with Richter transformation Cancer Genet. 2022; 260–261:18-22 2. Alaggio, R ∙ Amador, C ∙ Anagnostopoulos, I ∙ et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms Leukemia. 2022; 36:1720-1748 3.
Open in Who Shared Issue with article?

Chronic lymphocytic leukemia specificity analyses unveil bacterial lipopolysaccharides as the cognate ligands of established stereotyped BCR subsets - Blood Cancer Journal

|
By Arnon P Kater, Anton W. Langerak, Ten Feizi, Richard J. Bende, Jerry Janssen
| Nature Verified
Dear Editor, Chronic lymphocytic leukemias (CLLs) collectively express a biased immunoglobulin heavy variable (IGHV) gene repertoire with subgroups expressing stereotypic IGHV-IGHD-IGHJ gene rearrangements with (near-)identical VH-complementarity determining regions 3 (CDR3) [1,2,3].
Open in Who Shared Issue with article?
See all 22 licensed articles (34 Total)